1. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
   Yuan Cheng et al, 2019, Signal Transduction and Targeted Therapy CrossRef
2. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
   Lei Tao et al, 2024, MedComm – Oncology CrossRef
3. Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity
   Huarui Lu et al, 2016, Oncotarget CrossRef
4. Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT)
   Mi Lai et al, 2016, Molecular & Cellular Proteomics CrossRef
5. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells
   Ting Zhang et al, 2017, International Journal of Molecular Medicine CrossRef
6. DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications
   Niaz Mahmood et al, 2019, Frontiers in Oncology CrossRef
7. Molecular investigation of the tandem Tudor domain and plant homeodomain histone binding domains of the epigenetic regulator UHRF2
   Shane M. Ginnard et al, 2022, Proteins: Structure, Function, and Bioinformatics CrossRef
8. Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
   Marie-Claude Gingras et al, 2016, Cell Reports CrossRef
9. The UHRF protein family in epigenetics, development, and carcinogenesis
   Motoko UNOKI et al, 2022, Proceedings of the Japan Academy, Series B CrossRef
10. Uhrf2 deletion impairs the formation of hippocampus-dependent memory by changing the structure of the dentate gyrus
    Xiao-Rong Chen et al, 2018, Brain Structure and Function CrossRef
11. The Role of RNA Methylation Modification Related Genes in Prognosis and Immunotherapy of Colorectal Cancer
    Ruoyang Lin et al, 2023, International Journal of General Medicine CrossRef
12. Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women
    Mansoor Saleh et al, 2021, Translational Oncology CrossRef
13. Alterations of UHRF Family Expression and UHRF1/ICBP90 Inhibits Phosphatase and Tensin Homolog Expression in Endometrial Cancer
    Masafumi Yoshimoto et al, 2023, Oncology CrossRef
14. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma
    Tomohiro Iguchi et al, 2018, Oncology CrossRef
15. HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2
    Fengjuan Cheng et al, 2021, Hepatology International CrossRef
16. Organoids: opportunities and challenges of cancer therapy
    Xianjie Jiang et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
17. Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer
    Masafumi Yoshimoto et al, 2024, Experimental Cell Research CrossRef
18. METTL3-Modulated circUHRF2 Promotes Colorectal Cancer Stemness and Metastasis through Increasing DDX27 mRNA Stability by Recruiting IGF2BP1
    Miao Chen et al, 2023, Cancers CrossRef
19. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β‐catenin signaling
    Liang Li et al, 2020, International Journal of Cancer CrossRef